Paul Tudor Jones’s Genesis Healthcare, Inc. GEN Stock Holding History

Paul Tudor Jones’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-13,742	Closed	-$21K	–	1310
2018 Q1	$21K	Hold	13,742	–	–	﹤0.01%	963
2017 Q4	$10K	Hold	13,742	–	–	﹤0.01%	1063
2017 Q3	$16K	Hold	13,742	–	–	﹤0.01%	1058
2017 Q2	$24K	Hold	13,742	–	–	﹤0.01%	994
2017 Q1	$36K	Hold	13,742	–	–	﹤0.01%	1338
2016 Q4	$58K	Hold	13,742	–	–	﹤0.01%	1333
2016 Q3	$37K	Hold	13,742	–	–	﹤0.01%	1380
2016 Q2	$24K	Hold	13,742	–	–	﹤0.01%	1567
2016 Q1	$32K	Sell	13,742 -500	-4%	-$1.13K	﹤0.01%	1667
2015 Q4	$49K	Sell	14,242 -940	-6%	-$4.5K	﹤0.01%	1582
2015 Q3	$93K	Sell	15,182 -2,488	-14%	-$16.9K	﹤0.01%	1435
2015 Q2	$117K	Sell	17,670 -1,792	-9%	-$12.1K	﹤0.01%	1405
2015 Q1	$139K	Buy	+19,462	New	+$147K	﹤0.01%	1349

Other funds holding GEN

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $411M AUM 61.05% 1-Year Est. Return

VCM

V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CPA

Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GWS

Glassman Wealth Services Vienna, Virginia $835M AUM 22.94% 1-Year Est. Return

Paul Tudor Jones's GEN Position: Q2 2018 in Review

Paul Tudor Jones sold out of Genesis Healthcare, Inc. (GEN) in Q2 2018, closing a stake of 13,742 shares — an estimated $21K sold.

Paul Tudor Jones first reported a position in GEN in Q1 2015 and held it in 13 quarters. The position peaked at $139K in Q1 2015. 82 funds tracked by Wall St. Rank hold GEN as of Q2 2018.

Paul Tudor Jones reported no remaining Genesis Healthcare, Inc. position as of Q2 2018 after selling out during the quarter.
Paul Tudor Jones sold 13,742 Genesis Healthcare, Inc. shares in Q2 2018, an estimated $21K.
Paul Tudor Jones first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 13 quarters.
Paul Tudor Jones's Genesis Healthcare, Inc. position peaked at $139K in Q1 2015.
82 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2018.

Based on Tudor Investment Corp's 13F filing for Q2 2018, filed 14 Aug 2018.